Get the Stockscreener App
0.42
0.00%
0.00
iCo Therapeutics Stock (MSCLF) Forecast
The iCo Therapeutics (MSCLF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.5256, representing a +501.34% increase from the current price of $0.42. The highest analyst price target is $2.6234, and the lowest is $2.4278.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MSCLF Price Target
Average 2.5299
(+502.35% Upside)
Long-term MSCLF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about iCo Therapeutics financial reports and earnings history, iCo Therapeutics (MSCLF) stock could reach $5.5224 by 2030, $16.52 by 2040 and $30.45 by 2050. See the projected annual prices until 2050 of the iCo Therapeutics stock below:
- iCo Therapeutics (MSCLF) is expected to reach an average price of $13.24 in 2035, with a high prediction of $14.45 and a low estimate of $4.792. This indicates an $3,051% rise from the last recorded price of $0.42.
- iCo Therapeutics (MSCLF) stock is projected to chart a bullish course in 2040, with an average price target of $13.68, representing an $3,158% surge from its current level. The forecast ranges from a conservative $13.68 to a sky-high $16.52.
- Our analysts predict iCo Therapeutics (MSCLF) to jump 2,312% by 2045, soaring from $10.13 to an average price of $10.13, potentially reaching $13.91. While $10.13 is the low estimate, the potential upside is significant.
- iCo Therapeutics (MSCLF) stock is expected to climb by 2050, reaching an average of $26.38, a $6,181% jump from its current level. However, a wide range of estimates exists, with high and low targets of $30.45 and $26.38, respectively, highlighting the market's uncertainty.
iCo Therapeutics Stock (MSCLF) Year by Year Forecast
iCo Therapeutics Stock (MSCLF) Price Forecast for 2025
iCo Therapeutics Stock (MSCLF) is expected to reach an average price of $2.0649 in 2025, with a high prediction of $3.3324 and a low estimate of $0.7974. This indicates an +391.64% rise from the last recorded price of $0.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2025 | $2.6234 | $2.4278 | $2.6234 | +524.63% |
| September, 2025 | $1.3265 | $1.7464 | $2.2042 | +215.82% |
| October, 2025 | $1.3322 | $1.0324 | $1.6321 | +217.20% |
| November, 2025 | $2.8918 | $2.6418 | $3.3324 | +588.53% |
| December, 2025 | $2.2904 | $2.2904 | $2.8888 | +445.34% |
iCo Therapeutics Stock (MSCLF) Price Forecast for 2026
The predicted value for iCo Therapeutics (MSCLF) in 2026 is set at an average of $2.9361. Estimates vary from a peak of $4.7224 to a trough of $1.1499, indicating an +599.08% surge from the present price of $0.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.5374 | $1.5374 | $2.1369 | +266.05% |
| February, 2026 | $2.9728 | $1.1499 | $3.6799 | +607.82% |
| March, 2026 | $3.1541 | $2.9914 | $3.1541 | +650.98% |
| April, 2026 | $1.9985 | $1.9985 | $2.7021 | +375.83% |
| May, 2026 | $1.527 | $1.2674 | $1.7866 | +263.57% |
| June, 2026 | $3.4883 | $3.3039 | $4.0274 | +730.54% |
| July, 2026 | $2.569 | $2.571 | $3.4195 | +511.66% |
| August, 2026 | $1.8381 | $1.8381 | $2.1817 | +337.65% |
| September, 2026 | $3.635 | $1.3848 | $4.3749 | +765.47% |
| October, 2026 | $3.1999 | $3.1999 | $3.735 | +661.89% |
| November, 2026 | $2.3649 | $2.3649 | $2.9649 | +463.07% |
| December, 2026 | $4.7225 | $1.5023 | $4.7224 | +1,024% |
iCo Therapeutics Stock (MSCLF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for iCo Therapeutics (MSCLF) is $3.6924, with a high forecast of $5.7649 and a low forecast of $1.6198. This indicates an +779.13% increase from the last price of $0.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.8367 | $3.8367 | $4.0496 | +813.51% |
| February, 2027 | $3.0011 | $3.0032 | $3.9502 | +614.55% |
| March, 2027 | $2.1388 | $2.1388 | $2.5481 | +409.24% |
| April, 2027 | $4.5943 | $1.6198 | $5.0699 | +993.87% |
| May, 2027 | $3.6978 | $3.6978 | $4.3314 | +780.42% |
| June, 2027 | $2.7313 | $2.7313 | $3.4299 | +550.31% |
| July, 2027 | $5.4175 | $1.7373 | $5.4174 | +1,190% |
| August, 2027 | $4.4003 | $4.4003 | $4.6789 | +947.69% |
| September, 2027 | $2.7239 | $3.1438 | $4.4809 | +548.55% |
| October, 2027 | $2.0971 | $2.0971 | $2.9145 | +399.31% |
| November, 2027 | $5.2235 | $1.8548 | $5.7649 | +1,144% |
| December, 2027 | $3.9179 | $3.9179 | $4.9278 | +832.83% |
iCo Therapeutics Stock (MSCLF) Price Forecast for 2028
In 2028, iCo Therapeutics (MSCLF) is projected to reach an average price of $4.3898, with a high projection of $6.8074 and a low estimate of $1.9723. This indicates an +945.20% rise from the last price of $0.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.8201 | $2.8201 | $3.6493 | +571.45% |
| February, 2028 | $6.1125 | $1.9723 | $6.1124 | +1,355% |
| March, 2028 | $5.0116 | $4.9639 | $5.3082 | +1,093% |
| April, 2028 | $3.1232 | $3.5431 | $4.4445 | +643.61% |
| May, 2028 | $2.3649 | $2.3649 | $3.2809 | +463.08% |
| June, 2028 | $5.5757 | $2.0898 | $6.4599 | +1,228% |
| July, 2028 | $4.3829 | $4.3829 | $5.277 | +943.54% |
| August, 2028 | $2.8905 | $2.8905 | $4.0814 | +588.22% |
| September, 2028 | $5.9525 | $2.2073 | $6.8074 | +1,317% |
| October, 2028 | $5.5423 | $5.5274 | $5.9375 | +1,220% |
| November, 2028 | $3.6473 | $3.6473 | $4.9424 | +768.41% |
| December, 2028 | $2.8062 | $2.3248 | $3.2876 | +568.14% |
iCo Therapeutics Stock (MSCLF) Price Forecast for 2029
The 2029 price forecast for iCo Therapeutics Stock (MSCLF) is $5.3198 on average, with a high prediction of $8.1974 and a low estimate of $2.4422. This represents an +1,167% increase from the previous price of $0.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.1722 | $6.1767 | $7.1549 | +1,370% |
| February, 2029 | $4.8479 | $4.8479 | $5.8092 | +1,054% |
| March, 2029 | $3.1912 | $3.1912 | $4.5136 | +659.82% |
| April, 2029 | $6.6146 | $2.4422 | $7.5024 | +1,475% |
| May, 2029 | $5.4402 | $5.4402 | $6.5667 | +1,195% |
| June, 2029 | $4.0137 | $4.0137 | $5.0574 | +855.65% |
| July, 2029 | $3.0904 | $2.5597 | $3.6212 | +635.82% |
| August, 2029 | $6.3728 | $6.3728 | $7.8499 | +1,417% |
| September, 2029 | $4.9457 | $4.9478 | $6.3384 | +1,078% |
| October, 2029 | $3.4919 | $3.4919 | $4.1969 | +731.41% |
| November, 2029 | $7.426 | $2.6772 | $8.1974 | +1,668% |
| December, 2029 | $5.9381 | $5.9381 | $7.0153 | +1,314% |
iCo Therapeutics Stock (MSCLF) Price Forecast for 2030
iCo Therapeutics Stock (MSCLF) is expected to reach an average price of $6.0173 in 2030, with a high forecast of $9.2399 and a low forecast of $2.7947. This signifies an +1,333% surge from the last price of $0.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.9875 | $3.9875 | $5.5224 | +849.41% |
| February, 2030 | $8.545 | $2.7947 | $8.5449 | +1,935% |
| March, 2030 | $6.9363 | $6.9363 | $7.6078 | +1,552% |
| April, 2030 | $5.3778 | $5.3799 | $6.8691 | +1,180% |
| May, 2030 | $3.3024 | $3.3024 | $4.5634 | +686.28% |
| June, 2030 | $8.0553 | $2.9122 | $8.8924 | +1,818% |
| July, 2030 | $6.4359 | $6.4359 | $7.6117 | +1,432% |
| August, 2030 | $4.3211 | $4.3211 | $5.9873 | +928.82% |
| September, 2030 | $9.24 | $3.0297 | $9.2399 | +2,100% |
| October, 2030 | $7.3998 | $7.3998 | $8.27 | +1,662% |
| November, 2030 | $4.9199 | $5.3398 | $6.6849 | +1,071% |
| December, 2030 | $3.5702 | $3.5702 | $4.9298 | +750.05% |
5.71%
0.34%
Cap:
|
Volume (24h):